Manufacturer record
Jackson Laboratories Pvt.Ltd 22-24: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Jackson Laboratories Pvt.Ltd 22-24 (Punjab) were declared Not of Standard Quality between March 2020 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T-4714, Paroxetin Tablets IP 10 mg (exp Feb 2027). GORAKHPUR LAB (state lab) found it not of standard quality: The sample does not conform to IP in respect of Assay (content of Paroxetin). Listed in the August 2026 alert.
Records by type
14 records linked to Jackson Laboratories Pvt.Ltd 22-24 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paroxetin Tablets IP 10 mg | Batch T-4714Mfg Mar 2025 · Exp Feb 2027 | The sample does not conform to IP in respect of Assay (content of Paroxetin)Assay | GORAKHPUR LABState lab | Aug 2026 |
| Oxytocin Injection IP 5IU/ml, | Batch I-7881Mfg Nov 2025 · Exp Oct 2027 | The sample failed in Identification test of OxytocinIdentification | DTL, DelhiState lab | Jul 2026 |
| DICAL-500 | Batch T-4349Mfg Feb 2025 · Exp Jan 2027 | Thesample does not conform to I.P w.r.t the test for Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir, J&KState lab | Mar 2026 |
| Thiamine Tablets BP 100mg (Vitamin B1) | Batch T-4446Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to claim as per B.P. 2025 in respect to the Test of DescriptionDescription | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Dispersible Aspirin Tablets | Batch T-6705Mfg Jul 2025 · Exp Jun 2027 | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 | Batch T-6585Mfg Jul 2025 · Exp Jul 2027 | The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab | Dec 2025 |
| Gastro-Resistant Omeprazole Capsules BP 10 mg | Batch C-3023Mfg Oct 2024 · Exp Apr 2026 | The sample does not conform to claim as per B.P. in respect to the Test of Dissolution (Final Stage, PH 6.8)Dissolution | CDL, KolkataCDSCO lab | Nov 2025 |
| Bupivacaine Hydrochloride in Dextrose Injection USP (Bupivacaine Heavy) | Batch I-1468Mfg May 2024 · Exp Apr 2026 | The sample does not conform to U.S.P. with respect to Assay of Dextrose.Assay | CDL, KolkataCDSCO lab | Oct 2025 |
| Methyldopa Tablets IP 250 mg | Batch T-1939Mfg Jul 2024 · Exp Jun 2026 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Sitagliptin & Metformin Tablets 50mg + 1000mg (Sitajack-M) | Batch T-2672Mfg Sep 2024 · Exp Aug 2026 | Assay of SitagliptinAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Phenytoin Tablets IP 100 mg | Batch T-1150Mfg Apr 2024 · Exp Mar 2026 | The sample does not conforms w.r.t the test for descriptionDescription | DTL Srinagar (J&K) & MDTL Kathua (J&K)State lab | Feb 2025 |
| Iron & Folic Acid Syrup IP (JKMSCL Hospital Supply) | Batch SY-1641Mfg Aug 2023 · Exp Jul 2025 | The sample fails in the test for pH w.r.t the sample portion received.pH | CFDL Jammu (J&K)State lab | Jul 2024 |
| Cefuroxime Axetil Tablets I.P. (CEFUROX-S- 500) | Batch T-16940Mfg May 2018 · Exp Apr 2020 | Assay and DissolutionAssay | RDTL GuwahatiState lab | Apr 2020 |
| Telmijack- 40 (Telmisartan Tablets IP 40 MG) | Batch T-19301Mfg Apr 2019 · Exp Mar 2021 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Mar 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.